The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The main indications of Risperdal are related symptoms of schizophrenia, manic episodes in bipolar disorder, severe aggression in patients with dementia or schizophrenia-like symptoms.
Highlights
The global Risperdal market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Risperdal is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Risperdal is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Risperdal include Janssen (Johnson & Johnson), Ajanta Pharma, Amneal Pharmaceuticals, Aurobindo Pharma, Hikma, Sandoz, Lannett, Tris Pharma and Apotex, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Risperdal in Schizophrenia Patients is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Tablet, which accounted for % of the global market of Risperdal in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Risperdal, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Risperdal.
The Risperdal market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Risperdal market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Risperdal manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- Janssen (Johnson & Johnson)
- Ajanta Pharma
- Amneal Pharmaceuticals
- Aurobindo Pharma
- Hikma
- Sandoz
- Lannett
- Tris Pharma
- Apotex
- Celltrion
- Dr. Reddy's Laboratories
- Torrent Pharmaceuticals
- Luye Pharma Group
Product Type Insights
Global markets are presented by Risperdal type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Risperdal are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Risperdal segment by Type
- Tablet
- Oral Solution
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Risperdal market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Risperdal market.
Risperdal segment by Application
- Schizophrenia Patients
- Autistic Patient
- Manic Patient
- Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Risperdal market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Risperdal market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Risperdal and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Risperdal industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Risperdal.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Risperdal manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Risperdal in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index
1 Risperdal Market Overview
1.1 Product Overview and Scope of Risperdal
1.2 Risperdal Segment by Type
1.2.1 Global Risperdal Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Tablet
1.2.3 Oral Solution
1.3 Risperdal Segment by Application
1.3.1 Global Risperdal Sales Comparison by Application: (2022-2028)
1.3.2 Schizophrenia Patients
1.3.3 Autistic Patient
1.3.4 Manic Patient
1.3.5 Others
1.4 Global Risperdal Market Size Estimates and Forecasts
1.4.1 Global Risperdal Revenue 2017-2028
1.4.2 Global Risperdal Sales 2017-2028
1.4.3 Risperdal Market Size by Region: 2017 Versus 2021 Versus 2028
2 Risperdal Market Competition by Manufacturers
2.1 Global Risperdal Sales Market Share by Manufacturers (2017-2022)
2.2 Global Risperdal Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Risperdal Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Risperdal Manufacturing Sites, Area Served, Product Type
2.5 Risperdal Market Competitive Situation and Trends
2.5.1 Risperdal Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Risperdal Players Market Share by Revenue
2.5.3 Global Risperdal Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Risperdal Retrospective Market Scenario by Region
3.1 Global Risperdal Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Risperdal Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Risperdal Market Facts & Figures by Country
3.3.1 North America Risperdal Sales by Country
3.3.2 North America Risperdal Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Risperdal Market Facts & Figures by Country
3.4.1 Europe Risperdal Sales by Country
3.4.2 Europe Risperdal Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Risperdal Market Facts & Figures by Region
3.5.1 Asia Pacific Risperdal Sales by Region
3.5.2 Asia Pacific Risperdal Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Risperdal Market Facts & Figures by Country
3.6.1 Latin America Risperdal Sales by Country
3.6.2 Latin America Risperdal Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Risperdal Market Facts & Figures by Country
3.7.1 Middle East and Africa Risperdal Sales by Country
3.7.2 Middle East and Africa Risperdal Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Risperdal Historic Market Analysis by Type
4.1 Global Risperdal Sales Market Share by Type (2017-2022)
4.2 Global Risperdal Revenue Market Share by Type (2017-2022)
4.3 Global Risperdal Price by Type (2017-2022)
5 Global Risperdal Historic Market Analysis by Application
5.1 Global Risperdal Sales Market Share by Application (2017-2022)
5.2 Global Risperdal Revenue Market Share by Application (2017-2022)
5.3 Global Risperdal Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Janssen (Johnson & Johnson)
6.1.1 Janssen (Johnson & Johnson) Corporation Information
6.1.2 Janssen (Johnson & Johnson) Description and Business Overview
6.1.3 Janssen (Johnson & Johnson) Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Janssen (Johnson & Johnson) Risperdal Product Portfolio
6.1.5 Janssen (Johnson & Johnson) Recent Developments/Updates
6.2 Ajanta Pharma
6.2.1 Ajanta Pharma Corporation Information
6.2.2 Ajanta Pharma Description and Business Overview
6.2.3 Ajanta Pharma Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Ajanta Pharma Risperdal Product Portfolio
6.2.5 Ajanta Pharma Recent Developments/Updates
6.3 Amneal Pharmaceuticals
6.3.1 Amneal Pharmaceuticals Corporation Information
6.3.2 Amneal Pharmaceuticals Description and Business Overview
6.3.3 Amneal Pharmaceuticals Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Amneal Pharmaceuticals Risperdal Product Portfolio
6.3.5 Amneal Pharmaceuticals Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Corporation Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Aurobindo Pharma Risperdal Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 Hikma
6.5.1 Hikma Corporation Information
6.5.2 Hikma Description and Business Overview
6.5.3 Hikma Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Hikma Risperdal Product Portfolio
6.5.5 Hikma Recent Developments/Updates
6.6 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Sandoz Risperdal Product Portfolio
6.6.5 Sandoz Recent Developments/Updates
6.7 Lannett
6.6.1 Lannett Corporation Information
6.6.2 Lannett Description and Business Overview
6.6.3 Lannett Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Lannett Risperdal Product Portfolio
6.7.5 Lannett Recent Developments/Updates
6.8 Tris Pharma
6.8.1 Tris Pharma Corporation Information
6.8.2 Tris Pharma Description and Business Overview
6.8.3 Tris Pharma Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Tris Pharma Risperdal Product Portfolio
6.8.5 Tris Pharma Recent Developments/Updates
6.9 Apotex
6.9.1 Apotex Corporation Information
6.9.2 Apotex Description and Business Overview
6.9.3 Apotex Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Apotex Risperdal Product Portfolio
6.9.5 Apotex Recent Developments/Updates
6.10 Celltrion
6.10.1 Celltrion Corporation Information
6.10.2 Celltrion Description and Business Overview
6.10.3 Celltrion Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Celltrion Risperdal Product Portfolio
6.10.5 Celltrion Recent Developments/Updates
6.11 Dr. Reddy's Laboratories
6.11.1 Dr. Reddy's Laboratories Corporation Information
6.11.2 Dr. Reddy's Laboratories Risperdal Description and Business Overview
6.11.3 Dr. Reddy's Laboratories Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Dr. Reddy's Laboratories Risperdal Product Portfolio
6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.12 Torrent Pharmaceuticals
6.12.1 Torrent Pharmaceuticals Corporation Information
6.12.2 Torrent Pharmaceuticals Risperdal Description and Business Overview
6.12.3 Torrent Pharmaceuticals Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Torrent Pharmaceuticals Risperdal Product Portfolio
6.12.5 Torrent Pharmaceuticals Recent Developments/Updates
6.13 Luye Pharma Group
6.13.1 Luye Pharma Group Corporation Information
6.13.2 Luye Pharma Group Risperdal Description and Business Overview
6.13.3 Luye Pharma Group Risperdal Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Luye Pharma Group Risperdal Product Portfolio
6.13.5 Luye Pharma Group Recent Developments/Updates
7 Risperdal Manufacturing Cost Analysis
7.1 Risperdal Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Risperdal
7.4 Risperdal Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Risperdal Distributors List
8.3 Risperdal Customers
9 Risperdal Market Dynamics
9.1 Risperdal Industry Trends
9.2 Risperdal Market Drivers
9.3 Risperdal Market Challenges
9.4 Risperdal Market Restraints
10 Global Market Forecast
10.1 Risperdal Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Risperdal by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Risperdal by Type (2023-2028)
10.2 Risperdal Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Risperdal by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Risperdal by Application (2023-2028)
10.3 Risperdal Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Risperdal by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Risperdal by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Risperdal Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Risperdal Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Risperdal Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Risperdal Market Competitive Situation by Manufacturers in 2021
Table 5. Global Risperdal Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Risperdal Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Risperdal Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Risperdal Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Risperdal Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Risperdal Manufacturing Sites and Area Served
Table 11. Manufacturers Risperdal Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Risperdal by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Risperdal as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Risperdal Sales by Region (2017-2022) & (K Units)
Table 16. Global Risperdal Sales Market Share by Region (2017-2022)
Table 17. Global Risperdal Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Risperdal Revenue Market Share by Region (2017-2022)
Table 19. North America Risperdal Sales by Country (2017-2022) & (K Units)
Table 20. North America Risperdal Sales Market Share by Country (2017-2022)
Table 21. North America Risperdal Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Risperdal Revenue Market Share by Country (2017-2022)
Table 23. Europe Risperdal Sales by Country (2017-2022) & (K Units)
Table 24. Europe Risperdal Sales Market Share by Country (2017-2022)
Table 25. Europe Risperdal Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Risperdal Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Risperdal Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Risperdal Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Risperdal Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Risperdal Revenue Market Share by Region (2017-2022)
Table 31. Latin America Risperdal Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Risperdal Sales Market Share by Country (2017-2022)
Table 33. Latin America Risperdal Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Risperdal Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Risperdal Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Risperdal Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Risperdal Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Risperdal Revenue Market Share by Country (2017-2022)
Table 39. Global Risperdal Sales by Type (2017-2022) & (K Units)
Table 40. Global Risperdal Sales Market Share by Type (2017-2022)
Table 41. Global Risperdal Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Risperdal Revenue Share by Type (2017-2022)
Table 43. Global Risperdal Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Risperdal Sales (K Units) by Application (2017-2022)
Table 45. Global Risperdal Sales Market Share by Application (2017-2022)
Table 46. Global Risperdal Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Risperdal Revenue Share by Application (2017-2022)
Table 48. Global Risperdal Price by Application (2017-2022) & (US$/Unit)
Table 49. Janssen (Johnson & Johnson) Corporation Information
Table 50. Janssen (Johnson & Johnson) Description and Business Overview
Table 51. Janssen (Johnson & Johnson) Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Janssen (Johnson & Johnson) Risperdal Product
Table 53. Janssen (Johnson & Johnson) Recent Developments/Updates
Table 54. Ajanta Pharma Corporation Information
Table 55. Ajanta Pharma Description and Business Overview
Table 56. Ajanta Pharma Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Ajanta Pharma Risperdal Product
Table 58. Ajanta Pharma Recent Developments/Updates
Table 59. Amneal Pharmaceuticals Corporation Information
Table 60. Amneal Pharmaceuticals Description and Business Overview
Table 61. Amneal Pharmaceuticals Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Amneal Pharmaceuticals Risperdal Product
Table 63. Amneal Pharmaceuticals Recent Developments/Updates
Table 64. Aurobindo Pharma Corporation Information
Table 65. Aurobindo Pharma Description and Business Overview
Table 66. Aurobindo Pharma Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Aurobindo Pharma Risperdal Product
Table 68. Aurobindo Pharma Recent Developments/Updates
Table 69. Hikma Corporation Information
Table 70. Hikma Description and Business Overview
Table 71. Hikma Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Hikma Risperdal Product
Table 73. Hikma Recent Developments/Updates
Table 74. Sandoz Corporation Information
Table 75. Sandoz Description and Business Overview
Table 76. Sandoz Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Sandoz Risperdal Product
Table 78. Sandoz Recent Developments/Updates
Table 79. Lannett Corporation Information
Table 80. Lannett Description and Business Overview
Table 81. Lannett Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Lannett Risperdal Product
Table 83. Lannett Recent Developments/Updates
Table 84. Tris Pharma Corporation Information
Table 85. Tris Pharma Description and Business Overview
Table 86. Tris Pharma Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Tris Pharma Risperdal Product
Table 88. Tris Pharma Recent Developments/Updates
Table 89. Apotex Corporation Information
Table 90. Apotex Description and Business Overview
Table 91. Apotex Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Apotex Risperdal Product
Table 93. Apotex Recent Developments/Updates
Table 94. Celltrion Corporation Information
Table 95. Celltrion Description and Business Overview
Table 96. Celltrion Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Celltrion Risperdal Product
Table 98. Celltrion Recent Developments/Updates
Table 99. Dr. Reddy's Laboratories Corporation Information
Table 100. Dr. Reddy's Laboratories Description and Business Overview
Table 101. Dr. Reddy's Laboratories Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Dr. Reddy's Laboratories Risperdal Product
Table 103. Dr. Reddy's Laboratories Recent Developments/Updates
Table 104. Torrent Pharmaceuticals Corporation Information
Table 105. Torrent Pharmaceuticals Description and Business Overview
Table 106. Torrent Pharmaceuticals Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Torrent Pharmaceuticals Risperdal Product
Table 108. Torrent Pharmaceuticals Recent Developments/Updates
Table 109. Luye Pharma Group Corporation Information
Table 110. Luye Pharma Group Description and Business Overview
Table 111. Luye Pharma Group Risperdal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Luye Pharma Group Risperdal Product
Table 113. Luye Pharma Group Recent Developments/Updates
Table 114. Production Base and Market Concentration Rate of Raw Material
Table 115. Key Suppliers of Raw Materials
Table 116. Risperdal Distributors List
Table 117. Risperdal Customers List
Table 118. Risperdal Market Trends
Table 119. Risperdal Market Drivers
Table 120. Risperdal Market Challenges
Table 121. Risperdal Market Restraints
Table 122. Global Risperdal Sales Forecast by Type (2023-2028) & (K Units)
Table 123. Global Risperdal Sales Market Share Forecast by Type (2023-2028)
Table 124. Global Risperdal Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 125. Global Risperdal Revenue Market Share Forecast by Type (2023-2028)
Table 126. Global Risperdal Sales Forecast by Application (2023-2028) & (K Units)
Table 127. Global Risperdal Sales Market Share Forecast by Application (2023-2028)
Table 128. Global Risperdal Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 129. Global Risperdal Revenue Market Share Forecast by Application (2023-2028)
Table 130. Global Risperdal Sales Forecast by Region (2023-2028) & (K Units)
Table 131. Global Risperdal Sales Market Share Forecast by Region (2023-2028)
Table 132. Global Risperdal Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 133. Global Risperdal Revenue Market Share Forecast by Region (2023-2028)
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Risperdal
Figure 2. Global Risperdal Market Share by Type in 2021 & 2028
Figure 3. Tablet Product Picture
Figure 4. Oral Solution Product Picture
Figure 5. Global Risperdal Market Share by Application in 2021 & 2028
Figure 6. Schizophrenia Patients
Figure 7. Autistic Patient
Figure 8. Manic Patient
Figure 9. Others
Figure 10. Global Risperdal Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Risperdal Market Size (2017-2028) & (US$ Million)
Figure 12. Global Risperdal Sales (2017-2028) & (K Units)
Figure 13. Risperdal Sales Share by Manufacturers in 2021
Figure 14. Global Risperdal Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Risperdal Players: Market Share by Revenue in 2021
Figure 16. Risperdal Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Risperdal Sales Market Share by Region (2017-2022)
Figure 18. Global Risperdal Sales Market Share by Region in 2021
Figure 19. Global Risperdal Revenue Market Share by Region (2017-2022)
Figure 20. Global Risperdal Revenue Market Share by Region in 2021
Figure 21. United States Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Taiwan Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Colombia Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Risperdal Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Risperdal by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Risperdal
Figure 46. Manufacturing Process Analysis of Risperdal
Figure 47. Risperdal Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
